glp 1 trump administration drug price deal: Burning questions after Lilly, Novo agreement Lilly Agreement With Trump Administration
Description
Risk of dementia among persons with diabetes mellitus: a population-based cohort study
doi: 10.1093/ndt/gfaa380
Until recently, GLP-1s were only indicated and marketed for the management of type II diabetes
Importantly, the analysis excluded patients using the drugs for type 2 diabetes, for which GLP-1 medicines were originally developed
In dulaglutide, two modified DPP-4-resistant GLP-1 molecules are each fused to a modified F C fragment of human immunoglobulin 4 via a small peptide (Fig
BMJ 2023;382:p2019.Article 72
